MedPath

Link Between Plasma Citrulline and Lipopolysaccharide Concentrations in the Critically Ill

Conditions
Critically Ill
Registration Number
NCT02902276
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

In critically ill patients, the small bowel permeability is increased, leading to bacterial translocation, and systemic inflammatory response syndrome.

Plasma citrulline is a validated biomarker of functional enterocyte mass. Lipopolysaccharide (LPS) is a part of Gram negative bacteria, and plasma LPS concentration is a biomarker of bacterial translocation. The link between plasma citrulline and LPS in the critically ill is unknown. Investigators hypothesize that patients presenting with low plasma citrulline concentration, with presumed altered small bowel function, would have an increased phenomenon of bacterial translocation, and increased plasma LPS concentration. Investigators aimed to evaluate the link between plasma citrulline and LPS concentrations in critically ill patients at the time of ICU admission.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Critically ill patients requiring ICU admission for at least 48 hours
  • Adults
Exclusion Criteria
  • Chronic small bowel disease
  • Chronic renal failure (clearance of creatinine < 50 mL/min)
  • Pregnancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Plasma citrulline concentrationUp to 12 hours after admission in the unit

biological assay

plasma lipopolysaccharide concentrationUp to 12 hours after admission in the unit

biological assay

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre Hospitalier Universitaire de Besançon

🇫🇷

Besançon, France

© Copyright 2025. All Rights Reserved by MedPath